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Abstract 
A well described consequence of traumatic injury is immune dysregulation, where an initial 
increase in immune activity is followed by a period of immune depression, the latter leaving 
hospitalised trauma patients at an increased risk of nosocomial infections. Here, we discuss 
the emerging role of the neutrophil, the most abundant leukocyte in human circulation and 
the first line of defence against microbial challenge, in the initiation and propagation of the 
inflammatory response to trauma. We review the findings of the most recent studies to have 
investigated the impact of trauma on neutrophil function and discuss how alterations in 
neutrophil biology are being investigated as potential biomarkers by which to predict the 
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outcome of hospitalised trauma patients. Furthermore, with trauma-induced changes in 
neutrophil biology linked to the development of such post-traumatic complications as 
multiple organ failure and acute respiratory distress syndrome, we highlight an area of 
research within the field of trauma immunology that is gaining considerable interest: the 
manipulation of neutrophil function as a means by which to potentially improve patient 
outcome.  
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1.0 Introduction 
 
As the leading cause of morbidity and mortality in individuals aged 50 years and under, 
traumatic injury represents a major burden on the healthcare system, costing an estimated $27 
billion dollars per year in the USA alone1. Recent advancements in treatment, notably those 
targeting blood loss and coagulopathy, have markedly reduced mortality rates that are 
directly attributable to initial trauma. However, secondary complications, such as acute 
respiratory distress syndrome (ARDS), multiple organ failure (MOF) and nosocomial 
infections remain a significant cause of death in hospitalised trauma patients2. Trauma-
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induced changes in immune function are thought to be key drivers in the development of 
these conditions, with emerging evidence suggesting that alterations in the function of one 
particular cell type, the neutrophil, plays a decisive role.  
Equipped with a range of microbicidal defensive strategies, which include reactive oxygen 
species (ROS) production, degranulation, phagocytosis and the recently described generation 
of extracellular traps,3,4 neutrophils are the first line of defence against rapidly dividing 
bacteria, fungi and yeast. Across a range of time-points following traumatic injury, ex vivo 
studies have reported significant alterations in a multitude of neutrophil functions5-10, which 
are likely to contribute to the development of secondary complications. For instance, 
sequestration of hyperactive neutrophils in remote bystander organs is thought to underlie the 
development of both ARDS and MOF, whilst reduced neutrophil function may be one 
explanation for the increased susceptibility of hospitalised trauma patients to nosocomial 
infections2,11. 
In this review, we provide an update of the most recent studies to have investigated the 
impact that severe trauma has on neutrophil biology and summarise studies that have 
highlighted a pivotal role for neutrophils in the initiation and propagation of the inflammatory 
response to trauma. Furthermore, we discuss data that suggests alterations in neutrophil 
function may serve as a biomarker for predicting the outcome of hospitalised trauma patients 
and evaluate whether manipulating neutrophil function has potential as a future therapeutic 
strategy for the treatment of trauma patients. 
1.1 Impact of trauma on neutrophil biology  
Although it has been known for many years that traumatic injury leads to marked alterations 
in the phenotype, function and life-span of circulating neutrophils12-15, novel findings 
continue to be reported. Examples of these include the recent description of trauma-induced 
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changes in the composition of the circulating neutrophil pool16 and the observation that 
trauma serves as a stimulus for the generation of neutrophil extracellular traps17. Alongside 
these findings, it has become apparent through the use of proteomics and microRNA profiling 
that trauma has a significant impact upon neutrophil signalling18-20. In this section, we review 
the findings of the most recent studies to have investigated trauma-induced changes in 
neutrophil biology.   
1.1.1 Surface phenotype 
Surface expression of L-selectin, a receptor that facilitates tethering of neutrophils to the 
endothelium, has been shown to be significantly reduced on circulating neutrophils following 
blunt chest injury21, penetrative trauma22 and traumatic brain injury (TBI)6. Recently, 
Mommsen and co-workers found that stimulating neutrophils in vitro with tumour necrosis 
factor-alpha (TNF-α) resulted in shedding of L-selectin23, suggesting that exposure to a pro-
inflammatory environment may be one explanation for the reduced expression of L-selectin 
post trauma. Expression of CD11b, which forms part of the heterodimeric integrin Mac-1 that 
mediates firm adhesion to the endothelium, has been shown to be significantly increased 
following both TBI6 and thermal injury24. Combined with the data for L-selectin, this 
increase in CD11b expression suggests that systemic activation of the circulating neutrophil 
pool occurs following trauma.  
In addition to changes in the expression of adhesion receptors, neutrophils from trauma 
patients display an altered phenotype with respect to chemokine receptors. Studies have 
reported reduced expression of the interleukin (IL)-8 receptors CXCR1 and CXCR221;25 as 
well as the receptor for the complement component C5a, namely CD8821;26. Of interest, 
Visser et al21 studied the surface density of CXCR2 and CD88 on neutrophils obtained from 
patients that had suffered isolated blunt chest injury and found a significant reduction in their 
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expression 3-hours post injury21. By 24 hours, both CD88 and CXCR2 expression was 
comparable to that on neutrophils isolated from healthy volunteers, suggesting a transient 
activation of the circulating neutrophil pool21. 
Upon in vitro stimulation with the bacterial tripeptide formyl-methionine-leucine-
phenylalanine (fMLP), neutrophils from subjects that have suffered blunt, penetrative or head 
trauma fail to up-regulate the receptors CD11b and active FcγRII as efficiently as neutrophils 
from healthy controls21;27. In the case of active FcγRII, fMLP-induced expression of this 
receptor correlated negatively with injury severity score27 and was significantly lower on the 
surface of neutrophils isolated from subjects who subsequently developed secondary 
complications22;27. Thus, following trauma it appears that the responsiveness of circulating 
neutrophils to bacterial stimulation is suppressed.    
In the studies described above, receptor expression was analysed in isolation. Recently, a 
small number of groups have performed multi-colour flow cytometry on patient samples and 
reported that traumatic injury leads to the emergence of distinct neutrophil subsets, 
culminating in a neutrophil pool that is heterogeneous in both phenotype and function16;21;28. 
In severely injured patients, three distinct neutrophil subsets have been identified based on 
differential surface expression of the Fc receptor CD16 and L-selectin16. Defined as CD16DIM 
CD62LBRIGHT, CD16BRIGHT CD62LDIM or CD16BRIGHT CD62LBRIGHT these subsets differ in 
their expression of adhesion receptors (e.g. CD11b, CD11c and CD54) and function, with 
CD16BRIGHT CD62LDIM neutrophils producing significantly larger amounts of reactive 
oxygen species (ROS) upon fMLP stimulation than both CD16DIM neutrophils and 
neutrophils from healthy controls16. Interestingly, through the robust generation of ROS, 
CD16BRIGHT CD62LDIM neutrophils were shown in vitro to suppress both lymphocyte 
activation and proliferation, revealing an immunosuppressive function of this neutrophil 
subset that may contribute to the increased susceptibility of trauma patients to infection16. 
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Morphological assessment showed that circulating CD16DIM neutrophils possessed a 
“banded” nucleus, suggesting that trauma leads to the release of immature granulocytes from 
the bone marrow16. This observation, which has since been confirmed in patients with severe 
systemic inflammatory response syndrome (SIRS)28, supported a hypothesis made in an 
earlier study, where an influx of “young” neutrophils into the circulation was proposed to be 
responsible for the reduction in CD16 expression that was observed following blunt chest 
injury21.   
1.1.2 Chemotaxis 
Recent advancements in experimental techniques mean it is now possible to study specific 
features of the chemotactic process such as speed (chemokinesis), velocity (chemotaxis) and 
persistence. Through the use of these methods, neutrophils from thermally-injured subjects 
have been shown to exhibit significantly reduced chemokinesis when compared to 
neutrophils from healthy volunteers29. Interestingly, in this study, neutrophils from one 
thermally-injured patient demonstrated a level of chemokinesis that was comparable to that of 
neutrophils from healthy controls29. Detailed examination of this patient revealed the 
presence of a bacterial infection at the time of blood sampling, leading to the suggestion that 
preservation of neutrophil chemokinesis post burn injury may signify an existing infection 
and the need to begin immediate antibiotic therapy29. 
In addition to speed, the directionality of neutrophil movement is altered following thermal 
injury. Kurihara and colleagues9 demonstrated that when compared to those from sham 
controls, neutrophils from burn-injured rats exhibited defects in directionality during their 
migration towards fMLP9. It was suggested that if replicated in vivo, this impairment would 
not only hamper the recruitment of neutrophils to the site of injury but would lead to 
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considerable bystander tissue damage as neutrophils would degranulate at sites unaffected by 
burn injury9.  
1.1.3 Microbicidal function 
1.1.3.1 Phagocytosis and reactive oxygen species (ROS) generation 
Compared to values obtained for neutrophils from healthy controls, a significant increase in 
spontaneous ROS production as well as ROS generation induced by fMLP and Escherichia 
coli (E-coli) stimulation has been reported for neutrophils isolated from TBI patients6;10 and 
individuals that have suffered spinal cord injury (SCI)7;30. In the case of spontaneous ROS 
generation, this increase in oxidative activity was accompanied by a trauma-induced up-
regulation of gp91PHOX, a membrane residing subunit of the ROS generating enzyme 
nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) oxidase10;30. Interestingly, 
both spontaneous ROS generation and gp91PHOX expression by neutrophils isolated from TBI 
and SCI patients was significantly greater than that of neutrophils obtained from victims of 
blunt/penetrative trauma10;30, suggesting that neurological trauma results in a more robust 
systemic inflammatory response. Mechanistically, this has been proposed to be the result of a 
loss of feedback control of immune function in TBI and SCI patients due to damage to the 
central nervous system10.   
In contrast to ROS production, neutrophil phagocytosis is markedly impaired following 
neurological trauma, with the uptake of opsonised E-coli by neutrophils from TBI10 and SCI7 
patients significantly lower than that of neutrophils from healthy controls. This decline in 
phagocytosis has been suggested to represent a compensatory mechanism, where reduced 
phagocytosis offsets the deleterious effects that the abovementioned increase in ROS 
generation would have on bystander tissue10. However, reduced phagocytosis may also be 
detrimental to the host given that neutrophils are the first-line of defence against invading 
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microbes. Aberrant phagocytosis may explain in part the high incidence of nosocomial 
infections reported amongst patients following neurological trauma31;32. 
1.1.3.2 Generation of neutrophil extracellular traps (NETs) 
Consisting of a DNA backbone studded with histones and a multitude of granule-derived 
peptides and enzymes such as myeloperoxidase (MPO) and NE, neutrophil extracellular traps 
(NETs) are a recent addition to the defensive armamentarium of neutrophils3. Studied 
primarily in models of infection, NETs are renowned for their ability to capture and disarm 
invading pathogens3;33;34. However, in recent years it has become increasingly apparent that 
NETs are also generated at sites of sterile inflammation35;36.   
To date, only one study has categorically shown NET production to be a feature of the SIRS 
response that occurs after injury. Using DNA staining alongside antibodies specific for 
histone H1 and NE, Hamaguchi et al17 detected NETs in blood smear samples obtained from 
patients following thermal or traumatic injury. In other studies, the measurement of 
circulating cell-free DNA (cf-DNA) has been used as a surrogate marker of NET 
formation37;38. When compared to corresponding samples from healthy controls, 
serum/plasma taken from non-infectious SIRS patients37 and subjects that have suffered 
blunt/penetrating trauma38 have been found to contain significantly greater amounts of                  
cf-DNA. From these results, it has been inferred that NET formation occurs as part of the 
early inflammatory response to trauma38. However, in the absence of direct evidence showing 
that the cf-DNA measured in these studies was derived from activated neutrophils, only the 
work of Hamaguchi and colleagues17 can support this claim.  
Treating freshly isolated neutrophils from healthy volunteers with 20% plasma from SIRS 
patients has been shown to lead to NET release in vitro37. Thus, circulating soluble factors are 
likely to be responsible at least in part for the induction of NET formation that occurs 
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following traumatic injury17;37. Indeed, pre-treatment of SIRS plasma with antibodies against 
TNF-α, IL-1β and IL-8 was found to significantly reduce its ability to drive NET 
production37. Alongside pro-inflammatory cytokines, the nuclear protein high-mobility group 
box protein 1 (HMGB1), whose circulating levels are elevated following trauma39, may be 
another factor that triggers NET release. HMGB1 has been shown both in vitro and in vivo to 
induce NET formation by binding to the pathogen recognition receptor toll-like receptor 4 
(TLR4) on the neutrophil surface40.  
NETs have been proposed to function as double-edged swords of the innate immune 
system41. On the one hand, these structures are an effective form of anti-microbial defence 
via their ability to capture and neutralise invading microbes. However, under non-infectious 
conditions, the presence of histones and granule-derived peptides in the extracellular 
environment are likely to have detrimental effects for the host. In vitro, NET-bound histones 
and MPO induce epithelial and endothelial cell death42, whilst in vivo, NETs appear to serve 
as a stimulus for thrombus formation43-45. Thus, the release of NETs that occurs following 
traumatic injury17 may contribute not only to the onset of MOF but also the development of 
thrombosis, a secondary complication that has a high incidence amongst TBI and thermally-
injured patients46-48. Thus, targeting NETs either for degradation, via the administration of 
DNase, or neutralisation, by reducing the activity of the DNA-bound granule-derived 
proteins, may represent a novel therapy by which to protect trauma patients from NET-
induced endothelial damage and thrombosis38;45. However, given the potent anti-microbial 
properties of NETs, such strategies may increase the susceptibility of trauma patients to 
nosocomial infections and sepsis33.   
1.1.4 Apoptosis 
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In the absence of stimulation, neutrophils are short-lived cells, surviving in vitro for around 
8-12 hours before undergoing apoptosis. However, following traumatic injury, their life-span 
is markedly increased. In line with data published within the field of burns research15, Junger 
et al6 and Paunel-Gorgulu and co-workers49;50 have recently shown the rate of apoptosis for 
neutrophils isolated from TBI patients and victims of blunt/penetrating trauma respectively is 
significantly lower following overnight culture than that of neutrophils from uninjured 
controls6;49;50.  
Neutrophil apoptosis occurs through one of two independent pathways, namely intrinsic or 
extrinsic51. Alterations in the expression levels of molecules involved in the induction of both 
pathways have been observed following trauma, highlighting a potential mechanism for the 
abovementioned extension in neutrophil life-span. Mediated through the mitochondria, the 
intrinsic pathway of apoptosis is regulated in part by the Bcl-2 protein family. Anti or pro-
apoptotic in nature, Bcl-2 family proteins regulate mitochondrial membrane potential51. Thus, 
the balance between pro and anti-apoptotic proteins is a critical factor in the induction of 
apoptosis by the intrinsic pathway. Recently, neutrophils isolated from multiply injured 
patients (Injury severity score [ISS] >16) were found to express significantly greater amounts 
of the anti-apoptotic protein myeloid cell leukemia 1 (Mcl-1) and significantly lower levels of 
the pro-apoptotic protein Bax50;52, a balance that would favour stabilisation of mitochondrial 
membrane potential and cell survival. These findings were in line with those of an earlier 
study, where in a rodent model of thermal injury, increased expression of the anti-apoptotic 
protein Bcl-xL was found in neutrophils isolated from burnt rats when compared to those 
from uninjured controls53. The extrinsic pathway of apoptosis is initiated by ligation of 
surface expressed death receptors, an example of which is the TNF-α superfamily member 
Fas51. Increased levels of soluble Fas (sFas) have been reported in serum samples taken from 
patients with multiple blunt and penetrating injuries49. Interestingly, culturing neutrophils 
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from healthy donors in vitro with sera from critically-injured patients has been shown to 
markedly reduce apoptosis induced by the agonistic anti-Fas antibody CH11, demonstrating 
that sFas protects against the induction of the extrinsic pathway of apoptosis49. Indeed, a 
twofold increase in cell death was reported for CH-11 stimulated neutrophils that had been 
pre-treated with patient sera depleted of sFas49. Thus, based on these observations, it was 
proposed that the trauma-induced delay in neutrophil life-span is attributable in part to 
reduced activation of the extrinsic pathway of apoptosis49. 
Culturing neutrophils isolated from healthy volunteers overnight in the presence of serum 
from trauma patients has been shown to significantly prolong their life-span in vitro50;52. This 
suggests that circulating soluble factors mediate at least in part the delay in neutrophil 
apoptosis that occurs following injury. Indeed, Paunel-Gorgulu et al showed that treating 
serum from critically-injured patients with neutralising antibodies against the pro-
inflammatory cytokine granulocyte macrophage-colony stimulating factor (GM-CSF) 
significantly reduced its ability to delay neutrophil apoptosis in vitro52, an affect that 
appeared to occur through inhibition of the intrinsic pathway of apoptosis. Compared to those 
treated with sera from healthy controls, neutrophils exposed to serum obtained from trauma 
patients have been found to express significantly greater amounts of the anti-apoptotic protein 
Mcl-1, an elevation that was abolished when patient sera was pre-treated with neutralising 
antibodies against GM-CSF52. In addition to GM-CSF, IL-18 has been proposed to contribute 
to the delay in neutrophil apoptosis post trauma.  In a rodent model of burn injury, Akhtar 
and colleagues found that administration of an anti-IL-18 antibody to thermally-injured rats 
reversed the burn-induced delay in neutrophil apoptosis that was observed in untreated 
controls54. 
1.1.5 MicroRNA and proteomic profiling 
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To ascertain whether alterations to signalling pathways may underlie trauma-induced changes 
in neutrophil biology, comparative proteomics and microRNA (miRNA) profiling have been 
performed on neutrophils isolated from healthy controls and injured subjects18-20. 
MicroRNAs (miRNAs) are evolutionary conserved, small non-coding RNA molecules that 
assist in post transcriptional regulation55. In the first study of its kind in humans, Yang and 
colleagues18 recently described a unique miRNA signature in neutrophils following traumatic 
injury. Comparison of neutrophils from five control subjects and five severely injured 
patients (ISS ≥17) revealed that eight MiRNAs were significantly up-regulated and five 
MiRNAs were significantly down-regulated post trauma18. However, validation by qRT-PCR 
revealed only four miRNAs were significantly altered in neutrophils from patients with major 
trauma, namely hsa-miR-3945 and hsa-miR-125a-5p, which were both up-regulated and hsa-
miR-363-3p and hsa-miR-150-5p, which were both down-regulated18. Signalling pathways 
and genes associated with these altered MiRNAs included those involved in cell adhesion and 
ubiquitin-dependent protein catabolism18. A trauma-induced increase in neutrophil MiRNA 
expression had previously been reported in a rodent model of SCI, where at 12-hours post 
injury, a significant up-regulation in miR-223 levels was observed in neutrophils56. In this 
setting, an up-regulation in miR-223 expression may be a mechanism aimed at reducing 
neutrophil-mediated secondary damage to the spinal cord56. 
Two independent groups have recently investigated the impact of trauma on the neutrophil 
proteome19;20. Of these, Zhou et al compared the proteomic profile of neutrophils from five 
healthy donors and five severely injured subjects and reported a trauma-induced alteration in 
the abundance of 197 proteins, 144 of which were up-regulated and 53 down-regulated19. 
Analysis revealed proteins that were significantly up-regulated included those involved in 
interleukin signalling, chemokine signalling and pattern recognition19, which would be 
predicted to result in increased neutrophil reactivity. In addition, an up-regulation of proteins 
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with potential anti-apoptotic properties (e.g. caspase-1, cyclin-dependent kinase 2 and protein 
kinase B) was observed and accompanied by a significant down-regulation of proteins with 
potential pro-apoptotic properties19. Such changes would promote neutrophil survival and 
thus may contribute to the extended half-life of neutrophils following trauma6;49;50. 
1.2 Neutrophils in the initiation of the SIRS response to trauma 
The danger theory first proposed by Polly Matzinger in 1994 challenged the notion that the 
immune system functions simply by discriminating self from non-self by suggesting that “the 
immune system is more concerned with damage than foreignness, and is called into action by 
alarm signals from injured tissues rather than by the recognition of self”57. Since then, it has 
become increasingly recognised that tissue damage leads to the release of endogenous 
damage-associated molecular patterns (DAMPs). DAMPs can include substances which are: 
(i) secreted as a result of cellular activation such as HMGB-1, (ii) intracellular components 
such as mitochondrial DNA (mtDNA), which are released as a result of cellular necrosis, or 
(iii) extracellular matrix (ECM) components that are released upon tissue damage such as 
hyaluronic acid. DAMPs can be derived from a number of cellular compartments including 
the cytoplasm, mitochondria, nucleus and endoplasmic reticulum (ER). Like conserved 
pathogen-associated molecular patterns (PAMPs), which are expressed by invading 
pathogens, DAMPs can activate cells of the immune system via  a set of germ-line encoded 
pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and NOD-like 
receptors (NLRs), many of which are expressed by neutrophils. It has therefore been 
postulated that the activation of neutrophils by DAMPs, via their binding to PRRs, may play 
a role in the initiation of the SIRS response (Figure 1). This section will review the literature 
in support of this theory focussing on DAMPs that have been shown to be elevated in the 
circulation of trauma patients. 
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1.2.1 The expression of pattern recognition receptors on neutrophils 
Human neutrophils constitutively express all of the currently identified TLRs with the 
exception of TLR358. TLR1, TLR2, TLR4, TLR5 and TLR6 are primarily expressed on the 
cell surface, whereas TLR7, TLR8 and TLR9 are expressed intracellularly on endolysomal 
membranes58. Whilst TLRs are renowned for their ability to bind PAMPs, some of these 
receptors also bind endogenous DAMPs leading to cellular activation (see section 1.2.2). In 
addition to the TLRs, neutrophils express other PRRs capable of binding DAMPs. These 
include, the formyl peptide receptors FPR1 and FPR259, which bind mitochondria-derived 
DAMPs released following trauma, and the cytoplasmic nucleotide-binding oligomerization 
domain (NOD)-like receptor (NLR), NLRP3, which forms part of the inflammasome that 
binds a number of DAMPs60;61.  
1.2.2 The effect of DAMPs on neutrophil function 
High-mobility group box protein 1 (HMGB1) 
Originally described for its role in gen  expression and nucleosome remodelling62, HMGB1 
is one of the best characterised DAMPs, having a well-defined role in the response to tissue 
damage. This DNA-binding nuclear protein can be actively secreted in response to both pro-
inflammatory cytokines and cellular stress63;64. In a mouse model of endotoxemia, serum 
levels of HMBG1 were found to be elevated 8–32 hours following endotoxin exposure, 
sometime after the release of the pro-inflammatory cytokines TNFα and IL-1β65.  
Consequently, it is thought that HMGB1 acts as a late mediator of endotoxin driven 
inflammation. Furthermore, in patients with sepsis, those individuals who survived had 
significantly lower serum levels of HMGB1when compared to non-survivors65. 
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In addition to its active release, HMGB1 can be passively released from cells as a result of 
necrosis. Whilst HMGB1 is retained in the cell during apoptosis, as a result of irreversible 
binding to chromatin, it has been shown to be released from necrotic cells66. In 2006, Yang 
and colleagues demonstrated that trauma patients with hemorrhagic shock sampled within 6 
hours of injury displayed higher serum HMGB1 levels than controls67. More recently, 
HMGB1 plasma levels were shown to be significantly elevated following mechanical trauma 
(ISS ≥ 15), being 30 times greater than those in controls 1 hour after injury, and peaking 2-6 
hours post injury39. Moreover, high levels of HMGB1 have been shown to be associated with 
injury severity score and survival68. The release of HMGB1 into the circulation following 
trauma has since been linked to the subsequent inflammatory response. In an animal model of 
trauma, the blockade of HMGB1 using antagonistic antibodies prevented increases in 
pulmonary levels of the pro-inflammatory cytokines, IL-6, and IL-1β69. Consequently, 
HMGB1 is now accepted as an early and key mediator of sterile inflammation.  
Once released into the extracellular milieu, HMGB1 can activate immune cells via its binding 
to several receptors including TLR2, TLR470 and receptor for the advanced glycation end 
products (RAGE)71 all of which are expressed by neutrophils. Indeed, it has been 
demonstrated that HMGB1 can lead to the up-regulation of pro-inflammatory cytokine 
expression (IL-1β, TNFα and IL-8) in human neutrophils; an effect that was dependent on the 
activation of nuclear factor kappa beta (NFκB) and the p38 and extracellular signal-regulated 
kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) signalling pathways72. 
Similarly, a study by Silva et al showed that stimulation of neutrophils from sepsis-induced 
acute lung injury patients with HMGB1 up-regulated the gene expression of cytokines, 
chemokines and coagulation related genes, an effect that involved p38 and NFκB activation73. 
More recently, HMGB1 administration in mice has been shown to lead to the formation of 
neutrophil extracellular traps (NETs) via TLR440. In addition, intraperitoneal injection of 
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HMGB1 has been shown to promote mac-1 dependent neutrophil recruitment, an effect that 
was dependent on the expression of RAGE by neutrophils74. However, Tadie and colleagues 
found that incubation of mouse neutrophils with HMGB1 reduced neutrophil bacterial killing 
both in vitro and in vivo75. Based on this observation, the authors postulated that this may be 
a novel mechanism by which HMGB1 can potentiate sepsis-associated organ dysfunction. A 
recent publication has demonstrated that the effect of HMGB1 on neutrophils can depend 
upon its concentration. Berthelot and colleagues showed, using whole blood, that at low 
concentrations (50-100 ng/ml), HMGB1 was able to reduce neutrophil migration towards              
IL-8 whereas at higher concentrations (5000 ng/ml), HMGB1 had a chemoattractant affect 
via IL-8 production from an unidentified source76. 
Mitochondrial DAMPs 
Recently, it has been demonstrated that danger signals derived from mitochondria, so called 
mitochondrial DAMPs (mtDAMPs), are released into the circulation following trauma and 
are thus involved in the immune response to cellular damage77. Interestingly, mitochondria 
are proposed to originate from α-Protobacteria which lived as intracellular symbionts in 
eukaryotic cells78. As a result of this, mitochondria still display characteristics of their 
bacterial ancestors including methylated CpG DNA repeats and formylated peptides79. A full 
list of mitochondrial derived DAMPs is listed in Table 1.  
Zhang and colleagues have demonstrated that mtDNA is released into the circulation 
following trauma, where circulating levels amongst 15 trauma patients was 2.7μg/ml, which 
was thousands of fold higher than the levels detected in controls77. In addition, the same 
group were able to detect even higher levels of mtDNA in femur fracture reamings collected 
during clinical fracture repair80. It is thus well established that mtDAMPs are released into 
the circulation following tissue damage. It has also been demonstrated that mtDNA is 
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positively correlated with injury severity in a cohort of trauma patients81. In addition, a recent 
study has shown that circulating plasma mtDNA levels, measured within hours of admission 
to hospital, can act as an independent predictor of the occurrence of post-traumatic SIRS82. 
Furthermore, it has also been suggested that comparing plasma mtDNA levels to plasma 
bacterial DNA levels may help distinguish sterile systemic inflammation from bacterial 
sepsis83. 
It has been suggested that mtDAMPs released as a result of tissue damage may play a role in 
the initiation of the SIRS response via the activation of the immune system, ultimately 
resulting in the associated problems of MOF, ARDS and sepsis. Indeed, rats given an 
intravenous injection of mtDAMPs exhibited marked lung injury within hours of injection77. 
Moreover, this was shown to be via neutrophil activation as evidenced by the presence of 
neutrophils in the bronchoalveolar lavage as well as the accumulation of elastase in the 
lung77. In vitro, stimulation of human neutrophils with mtDAMPs has been shown to not only 
lead to the activation of both p38 and p42/44 MAPK77;80;84 but also induce the release of 
matrix metalloproteinases (MMP)-8 and MMP-9 along with interleukin (IL)-877;80;84. 
MtDAMPs have been shown to cause increased permeability of endothelial cells in vitro, in 
both a neutrophil-dependent and independent manner. mtDAMPs applied directly to 
endothelial cells in culture caused a significant increase in endothelial cell permeability, an 
effect abrogated by the addition of protease, suggesting a mitochondrial-protein dependent 
mechanism85. This effect was likely via the activation of the p38 and ERK MAPK pathways 
as both proteins were phosphorylated in response to the addition of mtDAMPs85. The same 
study also demonstrated that exposure to mtDNA increased the adherence of neutrophils to 
an endothelial cell layer via the up regulation of intercellular adhesion molecule 1 (ICAM-1) 
and E-selectin on the endothelial cells as well as CD18 and L-selectin on the neutrophil 
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surface85. Together, these data provide evidence that mtDAMPs released from sites of injury 
may contribute towards the increased endothelial permeability seen during SIRS. 
As well as leading to the increased adherence of neutrophils to endothelial cells, the work of 
Paul Kubes has elegantly shown that mtDAMPs play a central role in the recruitment of 
neutrophils to sites of focal hepatic necrosis in a mouse model of sterile inflammation86. In 
this model, it was demonstrated that neutrophils were able to adhere to the endothelium and 
migrate into the liver sinusoids within 30 to 60 minutes following injury. However, following 
administration of apyrase (an exogenous ATPase), there was a significant reduction in the 
number of neutrophils recruited to the liver in response to injury86. Interestingly, apyrase did 
not affect the chemotaxis of the few cells that were recruited. The effect of ATP was shown 
to be through the P2X7 receptor, which led to IL-1β and capsase-1 processing via the Nlrp3 
inflammasome86. This data shows therefore that ATP activates pathways that initiate 
neutrophil adhesion, but does not itself act as a chemotactic signal. In addition, the same 
study showed that mitochondrial derived formyl peptides released from necrotic tissue were 
responsible for providing the “necrotactic” signal necessary for the neutrophils to migrate the 
final 150µm to the site of necrosis86. This was demonstrated by the fact that in formyl-peptide 
receptor 1 knockout mice (Fpr1-/-), neutrophils migrated to within 150µm of the necrotic site 
(via CXCR2 mediated signalling) but failed to migrate to the area of injury86. Interestingly, it 
has recently been shown that blunt/penetrating injury and severe TBI leads to the up-
regulation of the A3 adenosine receptor on the surface of circulating human neutrophils, and 
that the level of expression of this receptor correlated positively with patient injury severity 
score87. Since ATP is released upon tissue damage, the up-regulation of A3 receptor 
expression may be one mechanism underlying the heightened activation status of circulating 
neutrophils from trauma patients.   
1.3 Neutrophil function as a predictor of outcome in traumatically-injured patients 
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In cohorts of critically-ill septic patients, neutrophil expression of the high affinity 
immunoglobulin receptor CD64 has been identified as a promising biomarker for the early 
diagnosis of bacterial infection, exhibiting a high sensitivity and specificity for predicting 
infection severity and patient mortality88-90. Surprisingly, despite the vast and marked 
alterations that occur in neutrophil biology post trauma, only two studies have investigated 
whether any of these changes could serve as biomarkers to predict the outcome of severely-
injured subjects, with both studies focusing upon NET generation91;92. In a cohort of forty-
five patients with multiple trauma, Margraf et al92 demonstrated that neutrophil-derived 
circulating free DNA (cf-DNA/NETs) could predict with high accuracy the posttraumatic 
development of sepsis in intensive care unit patients92. Following on from this study, 
Altrichter and colleagues have recently shown that an early measurement of cf-DNA/NETs 
has both a high sensitivity and specificity for predicting mortality in patients with severe burn 
injury91. Whilst the authors themselves stress that definite proof that the circulating cell-free 
DNA is derived from activated neutrophils is still needed, both these studies suggest that an 
early measurement of neutrophil function has potential as a prognostic marker for predicting 
patient outcome post trauma91;92. 
 
 
1.4 Manipulating neutrophil function and life-span: a potential therapeutic strategy for 
the treatment of trauma patients? 
As trauma-induced changes in neutrophil biology have been linked to the development of 
such common post-traumatic complications as MOF and ARDS93-96, investigating whether 
patient outcome can be improved via the manipulation of neutrophil function or life-span is 
an emerging theme in trauma research. 
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1.4.1 Animal studies 
To date, rodent models of traumatic injury and inflammation have been used to examine 
whether: (i) the removal of neutrophils from the circulation has potential as a form of 
treatment for the management of TBI97, (ii) reducing neutrophil infiltration into inflammatory 
lesions can improve outcome following SCI98, (iii) inflammatory lung injury can be 
prevented by limiting granulopoiesis99 and (iv) restoring neutrophil function following 
thermal injury can improve survival8;9. Regarding this latter strategy, Kinoshita et al8 
demonstrated that IL-18 treatment could significantly improve the survival rates of burn-
injured mice challenged with methicillin-resistant Staphylococcus aureus (MRSA)8. As well 
as increasing neutrophil counts, IL-18 treatment reversed the burn-induced depression in 
neutrophil phagocytosis that was observed in untreated burn-injured mice and also enhanced 
ROS production8. Thus, neutrophils from IL-18-treated mice exhibited MRSA-killing activity 
that was significantly greater than that of neutrophils from untreated burn-injured mice and 
comparable to that of neutrophils from sham mice8. Based on these observations amongst 
others, IL-18 treatment was proposed to be a potential therapeutic tool by which to fight the 
various kinds of bacterial infections encountered by hospitalised burns patients8. 
Interestingly, whilst not measured in this study, exposure to IL-18 had previously been shown 
in a model of alcohol intoxication and burn injury to prolong the life span of circulating 
neutrophils54. Together, these results suggest that IL-18 therapy would result in a longer-lived 
and more active neutrophil pool. Whilst these neutrophils would be beneficial in the context 
of fighting infection, a downside to IL-18 therapy would potentially be an increase in 
neutrophil-mediated tissue damage and organ failure54.  
1.4.2 Human studies 
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On the back of animal studies revealing that resuscitation with hypertonic fluids post trauma 
could reduce organ damage100, Junger and colleagues5;6 recently investigated whether by 
modulating the activation status and life span of circulating neutrophils, such a treatment 
regimen would be beneficial for human trauma patients. In the settings of TBI6 and 
hemorrhagic shock5, resuscitation with hypertonic saline (HS) was found to prevent trauma-
induced activation of neutrophils as assessed by alterations in receptor expression                      
(e.g. CD11b and L-selectin) and their ability to generate ROS ex vivo5;6. Furthermore, in the 
setting of TBI, treatment with hypertonic saline partially prevented the delay in apoptosis that 
was observed in vitro for neutrophils isolated from subjects that had received normal saline or 
HS containing dextran6. However, despite these immune-modulatory properties, in neither 
setting was pre-treatment with HS associated with any improvement in patient outcome5;6. 
As traumatic injury results in a heterogeneous pool of circulating neutrophils16;21;28, could the 
removal of individual neutrophil subsets represent a novel therapeutic approach for the 
treatment of severely-injured patients? Such a strategy is currently being considered as a 
potential future treatment for patients with sepsis101. Ex vivo filtration of blood from patients 
with septic shock using a Polymyxin-B filtration system has been found to preferentially 
remove neutrophils with an activated phenotype (CD11bhigh, CD64high and CXCR1/2low), 
whom in vitro caused considerable damage to endothelial monolayers102. This observation 
coupled with in vivo studies reporting that leucodepletion improves the outcome of patients 
with sepsis and septic shock103;104 has led to the suggestion that in cases of severe sepsis, 
removing activated neutrophils from the circulation could lead to patient benefit101. 
Currently, very little is known regarding whether such a strategy would be successful in 
severely injured subjects. Of note, one study reported that leucodepletion, which resulted in a 
forty percent reduction in circulating neutrophil numbers, improved the outcome of patients 
who developed SIRS following cardiopulmonary bypass105. Thus, it would be of interest if 
Page 23 of 39
Ac
ce
pte
d M
an
us
cri
pt
23 
 
future studies examined in cohorts of more severely injured subjects whether such an 
approach would also be beneficial. Furthermore, given the recent identification of a 
suppressive neutrophil subset in the circulation of traumatically-injured patients16, removing 
these cells via filtration may reduce the degree of immune suppression that occurs post 
trauma, a consequence of which could be a reduced risk of nosocomial infection.  
Although an interesting area of investigation, it should be said that attempting to manipulate 
neutrophil function in order to improve patient outcome is not without risk. Whilst enhancing 
the microbicidal capacity of neutrophils in order to protect against infection is on the one 
hand appealing, unregulated hyperactive neutrophils would cause considerable bystander 
tissue damage that underlies the development of ARDS and MOF. Conversely, attempting to 
dampen down the neutrophil inflammatory response in the immediate aftermath of a 
traumatic insult as a means by which to reduce immune-mediated tissue damage would leave 
the patient vulnerable to microbial infections. Developing strategies that will strike a balance 
between these two issues should be the focus of future studies that aim to modify the immune 
response in order to assist in patient recovery.   
1.5 Future directions 
Whilst ROS production and phagocytosis are the classic defensive strategies of neutrophils, 
these are not the only anti-microbial mechanisms utilised by these cells at sites of 
inflammation. Mesri et al were the first to demonstrate that neutrophils produce 
microparticles,  small (50-100nm) vesicles released into the extracellular environment from 
multivesiclular bodies106. Recently, these neutrophil derived microparticles have been shown 
to possess both anti-bacterial107 and immunomodulatory properties108. Interestingly, a recent 
study in trauma patients with ongoing sepsis demonstrated the presence of neutrophil-derived 
microparticles in the inflamed lungs and abdomen108. Whilst the exact immunomodulatory 
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role of neutrophil derived microparticles remains to be elucidated, such studies suggest that 
they may play a role in regulating the inflammatory response to trauma and thus provide a 
future target by which to modulate this response.   
In addition to their role in innate immunity, it is now recognised that neutrophils perform a 
number of other functions. For example, neutrophils interact with other cells of the immune 
system including dendritic cells (DCs) natural killer (NK) cells, B-cells and numerous subsets 
of T-cells (reviewed in reference 109).  In particular, a recent study has demonstrated a 
reciprocal cross-talk between neutrophils and Th17 cells110, which may have a role in 
amplifying neutrophil anti-bacterial function109. Given that IL-17 is released into the 
circulation following trauma111, this interaction may provide a future therapeutic target.  
Concluding Remarks 
Tissue damage as a result of traumatic injury leads to the release of endogenous DAMPs. 
These DAMPs are thought to be involved in the inflammatory response to sterile tissue injury 
ultimately leading to downstream complications such as MOF and sepsis. In addition, trauma 
has been shown to lead to an alteration in neutrophil function. Recent data has established a 
link between the release of DAMPs and altered neutrophil function in trauma. In particular, 
HMGB1 and mtDAMPs have been shown to activate neutrophils via their binding to PRRs 
expressed by the cells. Targeting DAMPs and their subsequent interaction with neutrophils 
via PRRs may therefore be a promising approach by which to reduce the initial SIRS 
response and the subsequent development of MOF and sepsis in trauma patients. 
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Figure Legend 
  
Figure 1. Damage Associated Molecular Patterns (DAMPs) and the neutrophil response 
to trauma. In response to traumatic injury, endogenous DAMPs are released into the 
circulation as a result of tissue damage, either from necrotic cells or through active secretion. 
Via interaction with surface expressed pattern recognition receptors, mitochondrial and 
nuclear derived DAMPs cause neutrophil activation triggering a multitude of functional 
responses that are thought to contribute to the initiation and propagation of the inflammatory 
response to trauma. ATP, adenosine triphosphate; FPR, formyl peptide receptor; HMGB1, 
high-mobility group box-1; mtDNA, mitochondrial DNA; NET, neutrophil extracellular trap; 
RAGE, receptor for advanced glycation end products; TLR, toll-like receptor. 
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Table 1. A list of mitochondrial damage-associated molecular patterns (DAMPs), their  
              receptors and effect on neutrophil function. 
  
 
 
 
 
 
  
Abbreviations: ATP, Adenosine triphosphate; FPR, Formyl-peptide receptor; IL-8, 
Interleukin-8; MtDNA, mitochondrial DNA; MMP, matrix metalloproteinase; TLR, Toll-like 
receptor. 
  
  
 
  
Mitochondrial 
DAMP 
  
  
Receptor 
  
Effect on neutrophils 
  
Reference(s) 
  
ATP 
  
  
P2X7 
  
Initiates adhesion 
  
[86] 
  
Cytochrome-C 
  
  
? 
  
Promotes neutrophil driven 
inflammation 
  
[112] 
  
mtDNA 
  
TLR9 
IL-8 release 
Adherence to endothelial cells 
Increased L-selectin, CD18 expression 
  
[77;84] 
  
  
  
Formyl Peptides 
  
  
FPR1, FPR2 
Chemotactic factor 
Ca2+ influx 
Ca2+ store depletion 
IL-8 release 
MMP-8 release 
MMP-9 release 
  
  
[77,80,84] 
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